Novolog (Pharm-Up 1966) Ltd reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was ILS 387.74 million compared to ILS 329.85 million a year ago. Net income was ILS 10.13 million compared to ILS 10.04 million a year ago. Basic earnings per share from continuing operations was ILS 0.02 compared to ILS 0.02 a year ago. Diluted earnings per share from continuing operations was ILS 0.02 compared to ILS 0.02 a year ago.
For the nine months, sales was ILS 1,124.5 million compared to ILS 955.58 million a year ago. Net income was ILS 34.16 million compared to ILS 32.78 million a year ago. Basic earnings per share from continuing operations was ILS 0.067 compared to ILS 0.065 a year ago. Diluted earnings per share from continuing operations was ILS 0.066 compared to ILS 0.064 a year ago.